Reuss and colleagues (37) have shown that MPNST cell lines with complete NF1 deficiency were sensitive to TRAIL-induced cell death, and TRAIL sensitivity was critically dependent on MYC. Thus, MYC may represent a therapeutic opportunity in NF1-associated MPNST. Here, NF1 is linked to malignant peripheral nerve sheath tumor.